CRL
$138.26
Charles River Laboratories Intl
$1.32
.96%
CRL
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $1.83
Revenue:  $687.36 Mil
Wednesday
Feb 5
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CRL reports earnings?
Beat
Meet
Miss

Where is CRL's stock price going from here?
Up
Flat
Down
Stock chart of CRL
Analysts
Summary of analysts' recommendations for CRL
Score
Grade
Pivots
Resistance
$141.09
$140.07
$139.17

$138.15

Support
$137.25
$136.23
$135.33
Tweet
Growth
Description
Charles River Laboratories is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies and has been in this business for more than 50 years.
Peers
Alexion PharmaceuticalsIncyteExact SciencesExelixisCoherus BiosciencesLuminex